Radiolabelled monoclonal antibodies in tumour diagnosis and therapyKOSMAS, C; KALOFONOS, H. P; EPENETOS, A. A et al.Developments in biological standardization. 1990, Vol 71, pp 93-102, issn 0301-5149, 10 p.Conference Paper

The role of monoclonal antibodies in tumour diagnosisKALOFONOS, H. P; EPENETOS, A. A.Cancer treatment reviews. 1986, Vol 13, Num 4, pp 243-252, issn 0305-7372Article

Monoclonal antibody targeting of ovarian carcinomaKOSMAS, C; KALOFONOS, H. P; HIRD, V et al.Oncology. 1998, Vol 55, Num 5, pp 435-446, issn 0030-2414Article

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patientsARGYRIOU, A. A; VELASCO, R; CAZZANIGA, M et al.Annals of oncology. 2012, Vol 23, Num 12, pp 3116-3122, issn 0923-7534, 7 p.Article

Pathophysiology and Pharmacological Targeting of Tumor-Induced Bone Disease: Current Status and Emerging Therapeutic Interventions : Targeted Cancer Therapies: Current Status and Future DirectionsLABROPOULOU, V. T; THEOCHARIS, A. D; SYMEONIDIS, A et al.Current medicinal chemistry. 2011, Vol 18, Num 11, pp 1584-1598, issn 0929-8673, 15 p.Article

Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer : A phase II study of the hellenic Co-operative Oncology GroupPECTASIDES, D; SAMANTAS, E; FOUNTZILAS, G et al.Lung cancer. 2007, Vol 58, Num 3, pp 355-361, issn 0169-5002, 7 p.Article

Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology GroupFOUNTZILAS, G; PAPAKOSTAS, P; CHRISTODOULOU, C et al.Annals of oncology. 2006, Vol 17, Num 10, pp 1560-1567, issn 0923-7534, 8 p.Article

Increased levels of albumin in bronchial washing fluid of patients with bronchial carcinoma. Could albumin be considered as a tumor marker?CHAROKOPOS, N; LEOTSINIDIS, M; TSIAMITA, M et al.The International journal of biological markers. 2004, Vol 19, Num 4, pp 316-321, issn 0393-6155, 6 p.Article

Irinotecan and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. A phase II study of the hellenic cooperative oncology groupPECTASIDES, D; FOUNTZILAS, G; RIGOPOULOS, A et al.Anticancer research. 2002, Vol 22, Num 6B, pp 3501-3506, issn 0250-7005, 6 p.Article

Preliminary results of the use of Re-186-HEDP for palliation of pain in patients with metastatic bone diseaseGIANNAKENAS, C; KALOFONOS, H. P; APOSTOLOPOULOS, D. J et al.American journal of clinical oncology. 2000, Vol 23, Num 1, pp 83-88, issn 0277-3732Article

Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune responseKALOFONOS, H. P; KOSMAS, C; HIRD, V et al.European journal of cancer. Part A. 1994, Vol 30, Num 12, pp 1842-1850Article

Kinetics, quantitative analysis and radioimmunolocalisation using indium-111-HMFG1 monoclonal antibody in patients with breast cancerKALOFONOS, H. P; SACKIER, J. M; HATZISTYLIANOU, M et al.British journal of cancer. 1989, Vol 59, Num 6, pp 939-942, issn 0007-0920Article

Targeted Therapy in Colorectal Cancer: Current Status and Future Challenges : Targeted Cancer Therapies: Current Status and Future DirectionsKOUTRAS, A. K; STARAKIS, I; KYRIAKOPOULOU, U et al.Current medicinal chemistry. 2011, Vol 18, Num 11, pp 1599-1612, issn 0929-8673, 14 p.Article

A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: A Hellenic Cooperative Oncology Group studyFOUNTZILAS, G; DAFNI, U; BRIASOULIS, E et al.Breast cancer research and treatment. 2009, Vol 115, Num 1, pp 87-99, issn 0167-6806, 13 p.Article

Effects of Epoetin-a on Quality of Life of Cancer Patients with Solid Tumors Receiving ChemotherapyCHRISTODOULOU, C; DAFNI, U; FOUNTZILAS, G et al.Anticancer research. 2009, Vol 29, Num 2, pp 693-702, issn 0250-7005, 10 p.Article

Impact of providing booklets about chemotherapy to newly presenting patients with cancer : a randomized controlled trialICONOMOU, G; VIHA, A; KOUTRAS, A et al.Annals of oncology. 2006, Vol 17, Num 3, pp 515-520, issn 0923-7534, 6 p.Article

Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer : a multicenter, randomized, phase II studyKALOFONOS, H. P; ARAVANTINOS, G; KARINA, M et al.Annals of oncology. 2005, Vol 16, Num 6, pp 869-877, issn 0923-7534, 9 p.Article

Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology GroupFOUNTZILAS, G; KALOFONOS, H. P; ECONOMOPOULOS, T et al.Annals of oncology. 2004, Vol 15, Num 10, pp 1517-1526, issn 0923-7534, 10 p.Article

Expression of the cell cycle regulatory proteins p34^cdc2, p21^waf1, and p53 in node negative invasive ductal breast carcinomaKOUREA, H. P; KOUTRAS, A. K; SCOPA, C. D et al.MP. Molecular pathology. 2003, Vol 56, Num 6, pp 328-335, issn 1366-8714, 8 p.Article

Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group StudyCHRISTODOULOU, C; PAVLIDIS, N; KOSMIDIS, P et al.Anticancer research. 2002, Vol 22, Num 6B, pp 3749-3757, issn 0250-7005, 9 p.Article

An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the hellenic co-operative oncology groupPECTASIDES, D; KALOFONOS, H. P; SAMANTAS, E et al.Anticancer research. 2001, Vol 21, Num 4B, pp 3005-3010, issn 0250-7005Article

Antibody guided targeting of non-small cell lung cancer using ¹¹¹In-labeled HMFG1 F(ab')₂ fragmentsKALOFONOS, H. P; SIVOLAPENKO, G. B; COURTENAY-LUCK, N. S et al.Cancer research (Baltimore). 1988, Vol 48, Num 7, pp 1977-1984, issn 0008-5472Article

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsCAVALETTI, G; CORNBLATH, D. R; KALOFONOS, H. P et al.Annals of oncology. 2013, Vol 24, Num 2, pp 454-462, issn 0923-7534, 9 p.Article

EGFR, HER-2 and COX-2 levels in colorectal cancerANTONACOPOULOU, A. G; TSAMANDAS, A. C; PETSAS, T et al.Histopathology. 2008, Vol 53, Num 6, pp 698-706, issn 0309-0167, 9 p.Article

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer : A Hellenic Cooperative Oncology Group (HeCOG) studyKOUTRAS, A. K; KALOGERAS, K. T; ZOGRAFOS, G et al.British journal of cancer. 2008, Vol 99, Num 11, pp 1775-1785, issn 0007-0920, 11 p.Article